Title:
CDK INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS
Document Type and Number:
WIPO Patent Application WO/2023/207875
Kind Code:
A1
Abstract:
Provided herein are CDK inhibitors, e.g., a compound of Formula (I), and pharmaceutical compositions thereof. Also provide herein is a method of their use for treating, preventing, or ameliorating a chemotherapy-induced gastrointestinal side effect.
Inventors:
LIU SHILAN (CN)
ZHANG SHIYI (CN)
ZHAO CHENGXU (CN)
ZHANG SHIYI (CN)
ZHAO CHENGXU (CN)
Application Number:
PCT/CN2023/090193
Publication Date:
November 02, 2023
Filing Date:
April 24, 2023
Export Citation:
Assignee:
ONQUALITY PHARMACEUTICALS CHINA LTD (CN)
International Classes:
C07D471/04; A61K31/519; C07D401/04; C07D487/04
Domestic Patent References:
| WO2021183994A1 | 2021-09-16 |
Foreign References:
| CN109516989A | 2019-03-26 | |||
| CN105622638A | 2016-06-01 | |||
| CN110623959A | 2019-12-31 | |||
| CN109071552A | 2018-12-21 |
Attorney, Agent or Firm:
SHANGHAI DIANSHI PARTNERS , P.C. (CN)
Download PDF: